XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Impairment, Restructuring and COVID-19 Related Charges (Tables)
9 Months Ended
Oct. 31, 2020
Restructuring And Related Activities [Abstract]  
Summary of Impairment Restructuring and COVID-19 Related Charges

The following table represents impairment, restructuring and COVID-19 related charges for the 13 and 39 weeks ended October 31, 2020 and November 2, 2019.  All amounts were recorded within impairment, restructuring and COVID-19 related charges on the Consolidated Statements of Operations.

 

 

 

13 weeks ended

 

 

39 weeks ended

 

 

 

October 31,

 

 

November 2,

 

 

October 31,

 

 

November 2,

 

(In thousands)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Impairment charges (1)

 

$

 

 

$

 

 

$

153,617

 

 

$

 

Incremental COVID-19 related expenses(2)

 

 

5,951

 

 

 

 

 

 

19,836

 

 

 

 

Severance and related employee costs

 

 

1,004

 

 

 

 

 

 

3,733

 

 

 

4,272

 

Total impairment, restructuring and COVID-19

   related charges

 

$

6,955

 

 

$

 

 

$

177,186

 

 

$

4,272

 

 

 

(1)

There were no impairment charges recorded during the 13 weeks ended October 31, 2020.  During the 39 weeks ended October 31, 2020, the Company recorded impairment charges of $153.6 million.  Of the total, $84.1 million related to the impairment of the operating lease ROU assets of 272 stores.  We recorded $51.5 million related to the impairment of certain corporate and store property and equipment.  We also recorded $18.0 million of impairment of certain cost and equity method investments.     

 

(2)

Incremental COVID-19 related expenses consist of personal protective equipment and supplies for our associates and customers.

Rollforward of Restructuring Liabilities Recognized in Accrued Compensation and Payroll Taxes and Other Current Liabilities and Accrued Expense in Consolidated Balance Sheets

A roll-forward of restructuring liabilities recognized in accrued compensation and payroll taxes and other current liabilities and accrued expenses in the Consolidated Balance Sheet is as follows:

 

 

 

39 Weeks Ended

 

 

 

October 31,

 

(In thousands)

 

2020

 

Accrued liability as of February 1, 2020

 

$

4,187

 

Add: Costs incurred, excluding non-cash charges

 

 

23,568

 

Less:  Cash payments and adjustments

 

 

(23,771

)

 

 

 

 

 

Accrued liability as of October 31, 2020

 

$

3,984